跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Co-Amoxed - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Co-Amoxed
Approved
STANDARD
Co-Amoxed
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1abd4060b50e3fbf
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
1abd4060b50e3fbf
Drug Approval Philippines Name
Co-Amoxed
Product Name
Co-Amoxed
Registration Number
DRP-8398-01
Brand Name
Co-Amoxed
Generic Name
Co-Amoxiclav
Dosage Form
Powder For Oral Suspension
Dosage Strength
250mg/62.5mg per 5mL
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
NELPA LIFESCIENCES, INC.
Distributor
777 Red Pharma Inc.
Issuance Date
27 June 2022
Expiry Date
12 May 2027
Pharmacologic Category
Antibacterial (Penicillins)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1abd4060b50e3fbf
Type
Standard
Back to Philippines FDA Approvals